Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17598409rdf:typepubmed:Citationlld:pubmed
pubmed-article:17598409lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:17598409lifeskim:mentionsumls-concept:C0017982lld:lifeskim
pubmed-article:17598409lifeskim:mentionsumls-concept:C1420192lld:lifeskim
pubmed-article:17598409pubmed:issue1lld:pubmed
pubmed-article:17598409pubmed:dateCreated2007-6-29lld:pubmed
pubmed-article:17598409pubmed:abstractTextAlthough the majority of eukaryotic proteins are glycosylated, there is a dearth of knowledge regarding protein sugar moieties and their changes in disease. Most multiple myeloma cases are characterized by production of monoclonal immunoglobulins (Ig). We studied galactosylation and sialylation of IgG heavy chains in 16 patients with IgG myeloma using lectin blotting and densitometry. In comparison to age and sex matched controls, galactosylation was reduced in multiple myeloma (median 317 vs. 362, range 153-410 vs. 309-447 relative units, p = 0.015, Student's t-test). Sialylation was stage dependent; samples from patients with stage IIA had lowest amounts of sialic acid, IIIA intermediate and IIIB highest (142.6 vs. 185.9 vs. 248.5 relative units, correlation coefficient r = 0.55). Both galactosylation and sialylation levels were independent of age, sex, treatment type, response to treatment, disease duration and IgG and b2 microglobulin concentration. These data indicate that multiple myeloma is characterized by aberrant immunoglobulin glycosylation.lld:pubmed
pubmed-article:17598409pubmed:languageenglld:pubmed
pubmed-article:17598409pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17598409pubmed:citationSubsetIMlld:pubmed
pubmed-article:17598409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17598409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17598409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17598409pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17598409pubmed:statusMEDLINElld:pubmed
pubmed-article:17598409pubmed:monthMarlld:pubmed
pubmed-article:17598409pubmed:issn0350-6134lld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:Heffer-LaucMa...lld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:LaucGordanGlld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:AurerIgorIlld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:LabarBorisBlld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:Rendi?Dubravk...lld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:Dumi?JerkaJlld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:FlogelMirnaMlld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:Matisi?Danica...lld:pubmed
pubmed-article:17598409pubmed:authorpubmed-author:MilosMarijaMlld:pubmed
pubmed-article:17598409pubmed:issnTypePrintlld:pubmed
pubmed-article:17598409pubmed:volume31lld:pubmed
pubmed-article:17598409pubmed:ownerNLMlld:pubmed
pubmed-article:17598409pubmed:authorsCompleteYlld:pubmed
pubmed-article:17598409pubmed:pagination247-51lld:pubmed
pubmed-article:17598409pubmed:dateRevised2009-2-4lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:meshHeadingpubmed-meshheading:17598409...lld:pubmed
pubmed-article:17598409pubmed:year2007lld:pubmed
pubmed-article:17598409pubmed:articleTitleAberrant glycosylation of Igg heavy chain in multiple myeloma.lld:pubmed
pubmed-article:17598409pubmed:affiliationDivision of Hematology, Department of Internal Medicine, University Hospital Center and Medical School, Zagreb, Croatia. aurer@mef.hrlld:pubmed
pubmed-article:17598409pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17598409pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17598409lld:pubmed